Insider · CIK 0001914164

Atkinson Edward Morrow III

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001914164

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−668 sh	$486.35	−$325K	18,432
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,627 sh	$485.11	−$789K	19,100
2026-02-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−817 sh	$473.68	−$387K	20,727
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−2,031 sh	$489.46	−$994K	21,544
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,530 sh	$483.75	−$740K	23,575
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+4,962 sh	—	—	25,105
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,903 sh	$487.76	−$928K	20,143
2026-02-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−1,751 sh	$460.43	−$806K	22,046
2026-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−872 sh	$468.41	−$408K	23,797
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+3,883 sh	—	—	24,669
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+3,934 sh	—	—	20,786
2025-11-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−2,500 sh	$434.58	−$1.09M	16,852
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56.4K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.2K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2025-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−2,650 sh	$475.34	−$1.26M	19,352
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−2,482 sh	$479.61	−$1.19M	22,002
2025-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−1,767 sh	$480.95	−$850K	24,484
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,656 sh	$483.28	−$800K	26,251
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,529 sh	$463.46	−$709K	27,907
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+6,211 sh	—	—	29,436
2025-02-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−1,747 sh	$459.83	−$803K	23,225
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−876 sh	$467.98	−$410K	24,972
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+5,132 sh	—	—	21,104
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+4,744 sh	—	—	25,848
2025-02-03	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.4K sh	—	—	56,400
2024-06-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−7,288 sh	$478.00	−$3.48M	15,972
2024-06-11	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−6,824 sh	$481.96	−$3.29M	23,260
2024-05-14	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+14.1K sh	—	—	30,084
2024-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−883 sh	$425.70	−$376K	15,972
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,654 sh	$431.79	−$714K	16,855
2024-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−1,201 sh	$421.77	−$507K	18,509
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−801 sh	$420.79	−$337K	19,710
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,125 sh	$420.58	−$473K	20,511
2024-02-16	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−1,501 sh	$424.01	−$636K	21,636
2024-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Technical Ops. Off.	SSale	−913 sh	$420.24	−$384K	23,137
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Technical Ops. Off.	FTax Payment	−832 sh	$422.74	−$352K	24,050
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+4,743 sh	—	—	24,882
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+3,934 sh	—	—	20,139
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Technical Ops. Off.	AAward	+2,326 sh	—	—	16,205
2024-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.2K sh	—	—	45,150
2023-06-01	ETNB89bio, Inc.S Sale	Director	SSale	−6,250 sh	$17.91	−$112K	0
2023-06-01	ETNB89bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$2.61	+$16.3K	6,250
2023-06-01	ETNB89bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	0
2023-03-01	ETNB89bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	20,000
2023-03-01	ETNB89bio, Inc.S Sale	Director	SSale	−10K sh	$13.60	−$136K	0
2023-03-01	ETNB89bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.44	+$44.4K	10,000
2023-02-09	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2022-05-25	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,250 sh	—	—	6,250

Recent filings

Accepted (ET)
Feb 264
Atkinson Edward Morrow III0000875320-26-000106
SEC(opens sec.gov)
Feb 194
Atkinson Edward Morrow III0000875320-26-000082
SEC(opens sec.gov)
Feb 184
Atkinson Edward Morrow III0000875320-26-000060
SEC(opens sec.gov)
Feb 124
Atkinson Edward Morrow III0000875320-26-000038
SEC(opens sec.gov)
Jan 264
Atkinson Edward Morrow III0000875320-26-000012
SEC(opens sec.gov)
Nov 194
Atkinson Edward Morrow III0000875320-25-000236
SEC(opens sec.gov)
Oct 304
Atkinson Edward Morrow III0001193125-25-259047
SEC(opens sec.gov)
Feb 284
Atkinson Edward Morrow III0000875320-25-000127
SEC(opens sec.gov)
Feb 264
Atkinson Edward Morrow III0000875320-25-000107
SEC(opens sec.gov)

Companies

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210